Samaritan Receives AMEX Compliance Notice Letter
13th Nov 2006, 20:17 GMT
Samaritan Pharmaceuticals announced that on 11/6/2006, it received a notice from the American Stock Exchange (``AMEX'') informing the Company it is not in compliance with certain AMEX continued listing standards.
Samaritan Receives AMEX Compliance Notice Letter related news:
- Samaritan Receives AMEX Compliance Notice Letter — ArriveNet : Business
- Samaritan Gets AMEX Compliance Warning — Financial News News from StratCenter.com
- Transnational Financial Receives Notice of Extension to Regain Compliance With AMEX Listing Standards — DBusiness News - San Francisco
- Samaritan Arrives at Definitive Agreement to Acquire Metastatin to Expand Cancer Pipeline — ArriveNet : Press Releases
- JMAR Receives Nasdaq Delisting Notice — Financial News News from StratCenter.com
- Insight Enterprises receives delisting notification — Latest news from The Business Journal of Phoenix
- Sonus Networks Receives Expected Q3 2006 Nasdaq Staff Letter Noting Delayed 10-Q Filing — VoIP Developer
- QUMAS: Compliance Risk Equates to Brand Risk -- Savvy Financial Services Firms are Incorporating Compliance Risk Into Mainstream Risk Management — ArriveNet : Technology
- ECM, Not Just Compliance — BIOS Opinions: The Quality Tech Guide
- QUMAS: QUMAS: Compliance Risk Equates to Brand Risk -- Savvy Financial Services Firms are Incorporating Compliance Risk Into Mainstream Risk Management — Market Wire - Computers and Software
Latest news from Financial News News from StratCenter.com:
- TRADE NEWS: Agilent Technologies Introduces High-Speed, High-Volume USB Multifunction Data Acquisition Modules, Chassis
- Bio-Rad Closes Buy of Ciphergen Unit
- The LGL Group Reports Q3 Earnings
- Analogic CEO to retire
- Analogic CEO Plans to Retire
- Meade Instruments Contracts with Leading Asian Outsource Manufacturing Firm
- JMAR Receives Nasdaq Delisting Notice
- Analogic Corp Announces Mgmt Changes
- Bio-Rad Purchases Life Science Research Business From Ciphergen Biosystems
- Agilent to buy Switzerland's Acqiris